Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06428253
Status:
RECRUITING
Last Update Posted:
2024-05-24
First Post:
2024-05-20
Brief Title:
Efficacy and Safety of HMM1-022 in Temporary Correction of Crows Feet
Sponsor:
Humedix Co Ltd
Organization:
Humedix Co Ltd
Study Overview
Official Title:
A Single Center Subject Evaluator-blind Randomized Matched Pairs Active-controlled Confirmatory Study to Evaluate the Efficacy and Safety of HMM1-022 in Temporary Correction of Crows Feet
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the efficacy and safety of HMM1-022 with Rejuran to improve Crows feet
Detailed Description:
A single center subject evaluator-blind randomized matched pairs active-controlled confirmatory study to evaluate the efficacy and safety of HMM1-022 in temporary correction of Crows feet
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None